Prime Medicine Operating Income Growth & History (PRME)

Prime Medicine's operating income was −$208.3M for fiscal 2025.

View full Prime Medicine company overview

Prime Medicine annual operating income history

Prime Medicine annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20252025-12-31−$208.3M−$5.9M
20242024-12-31−$202.5M$2.3M
20232023-12-31−$204.8M−$88.2M
20222022-12-31−$116.5M−$32.1M
20212021-12-31−$84.5M−$83.5M
20202020-12-31−$932,000

Prime Medicine operating income trends

Over the last five fiscal years, Prime Medicine's operating income decreased from −$932,000 to −$208.3M, a change of −$207.4M. The latest reported quarter, Q2 2026, shows −$43.3M.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Prime Medicine source filings ↗

Community posts

It’s quiet here.

No posts about PRME yet. Start the conversation.

Write the first post